Nektar Therapeutics is a global biopharmaceutical company that specializes in the discovery and development of innovative therapies to selectively modulate the immune system and effectively treat autoimmune disorders. With a profound understanding of immunology and extensive expertise in polymer chemistry, Nektar Therapeutics creates unique and highly-targeted medicines that provide optimal therapeutic benefits. Their success is built upon several key factors.

Firstly, they have a proven track record of discovering and delivering life-changing medicines that are globally commercialized through partnerships with pharmaceutical companies. Secondly, their deep understanding of immunology and longstanding expertise in polymer chemistry drive their ongoing research and development efforts. Thirdly, Nektar Therapeutics offers a portfolio of innovative therapeutics that selectively modulate the immune system for the advancement of autoimmune disorder treatment and the management of chronic inflammatory conditions.

Nektar Therapeutics is powered by a dedicated team of scientists, clinicians, and employees who are committed to bringing new medicines to patients suffering from debilitating diseases. Through their relentless pursuit of medical breakthroughs, Nektar Therapeutics aims to make a positive impact on the lives of patients worldwide